Skip navigation

Industry Best Practices and Strategies for Managing and Enhancing Ethics and Integrity Programs

June 5-7, 2018
  • Toronto, Canada

On the heels of our highly-acclaimed inaugural event, CBI’s 2nd Annual Pharmaceutical Compliance Congress Canada convenes top Canadian compliance practitioners and leading experts to discuss effective strategies to achieve organization-wide compliance, from the compliance and legal teams to the oversight of the promotional marketing and sales teams. Join your Canadian colleagues for robust conversations on the top issues facing industry today.

JOIN OUR LIST FOR PROGRAM UPDATES!

Key Learnings and Takeaways Include:

  • Engage the organization in supporting a culture of compliance
    and ethics — Connect the benefits of compliance to
    the business at large
  • Construct ethical interactions with stakeholders —
    Identify and manage perceived conflicts
  • Understand the implications of the transparency reporting
    requirements within the Strengthening Quality and
    Accountability for Patients Act, 2017
  • Examine strategies to maintain the integrity of medical affairs,
    patient support programs and patient advocacy groups —
    Ensure that your interactions remain compliant
  • Consider trends in HCP transparency reporting —
    Guidance on a national and global level
  • Discuss emerging issues in data privacy and data security —
    Best practices to safeguard patient privacy from social media
    and internet data leakage
  • Review potential areas of conflict of interest around pharmaceutical
    manufacturers’ interactions with the drug supply chain —
    Including wholesalers, specialty pharmacies, banners and HCPs
  • Explore effective strategies for managing conflict of interest and
    ethics — Perception versus reality
  • And much more!

Previous Attendee Acclaim:

The conference is on-point for anyone in
the compliance world in Canada.

Medical Compliance, Janssen

It was great learning what worked and didn’t work for other companies in terms of raising the awareness of compliance with my own respective pharmaceutical company.

Compliance Specialist, Sanofi-Pasteur

Excellent conference!
Worth taking two days from work.

Chief Compliance Officer, Boehringer Ingelheim

I came from the finance side — Good learning topics
and possibilities to do networking.

Accounting Services Supervisor, AbbVie

This conference is yet another important step towards fostering a diverse, tightly knit community of
Canadian compliance professionals.

Counsel, Gilead Sciences